- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rxsight Inc (RXST)
The Rxsight share price today is 6.78, view NASDAQ RXST stock exchange data. Track the latest Rxsight share price with real-time updates on RXST stock performance including market cap, day range, 52-week range and dividend yield. Access RXST charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.75
7.26
52 wk Range
5.90
16.74
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.757.26
52 wk Range
5.9016.74
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RXST Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
9.79
Upside
+44.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
6 Hold
2 Sell
Ratings:
9 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 9.79
(+44.33% Upside)
Rxsight Inc Earnings Call Summary for Q1/2026
- RxSight Q1 2026 EPS of -$0.19 beat forecast of -$0.31; revenue of $30.9M exceeded $29.75M estimate despite 18% YoY decline.
- Gross margins improved to 76.1% from 74.8% YoY, driven by higher Light Adjustable Lens sales mix; net loss totaled $15.9M.
- Stock fell 1.93% to $7.12 in aftermarket trading despite earnings beat, down 30% YTD and nearly 48% over past year.
- Full-year 2026 revenue guidance maintained at $120M-$135M; gross margins expected at 70-72%, operating expenses at high end of $150M-$160M.
- CEO emphasized re-engagement opportunities with installed base; company investing in global expansion amid competitive pressures from new IOL entrants.
Last Updated: 07-05-2026, 03:00 am
Read Full TranscriptEarnings
Latest Release
06-05-2026
EPS / Forecast
-0.19 / -0.31
Revenue / Forecast
30.9M / 29.75M
Compare RXST to Peers and Sector
Metrics to compare | RXST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRXSTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.7x | −4.2x | −0.5x | |
PEG Ratio | 0.22 | −0.20 | 0.00 | |
Price/Book | 1.1x | 3.9x | 2.6x | |
Price / LTM Sales | 2.2x | 3.2x | 3.2x | |
Upside (Analyst Target) | 24.0% | 51.0% | 47.8% | |
Fair Value Upside | Unlock | 9.3% | 5.9% | Unlock |
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Rxsight (RXST) Share Price Today?
The Rxsight share price today is 6.78.
What is the current Rxsight (RXST) share price and day range?
As of 06-05-2026, the Rxsight share price is 6.78, with a previous close of 7.26. The share price has ranged from 6.75 to 7.26 today, while the 52-week range spans from 5.90 to 16.74.
What Is the Rxsight Market Cap?
As of today, Rxsight market cap is 280.20M.
What Is the Rxsight (RXST) Share Price Target?
The average 12-month share price target for Rxsight is 9.79, with a high estimate of 13 and a low estimate of 8. 1 analysts recommend buying, while 2 suggest selling, with an overall rating of Neutral and +44.33% Upside potential.
What Is Rxsight's Earnings Per Share (TTM)?
The Rxsight EPS (TTM) is -0.95.
When Is the Next Rxsight Earnings Date?
Rxsight will release its next earnings report on 06-05-2026.
From a Technical Analysis Perspective, Is RXST a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Rxsight Trade On?
Rxsight is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Rxsight?
The stock symbol for Rxsight is "RXST."
How Many Times Has Rxsight Stock Split?
Rxsight has split 0 times.
How Many Employees Does Rxsight Have?
Rxsight has 461 employees.
What Is the RXST Premarket Price?
RXST's last pre-market stock price is 7.12. The pre-market share volume is 7,670.00, and the stock has changed by -0.14, or -1.93%.
What Is the RXST After Hours Price?
RXST's last after hours stock price is 6.55, the stock has changed by -0.23, or -3.39%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.